New evidence now suggests that the dominant mechanism of extravasation of nanoparticles into solid tumours may be through an active process of endothelial transcytosis.
References
Gerlowski, L. E. & Jain, R. K. Microvasc. Res. 31, 288–305 (1986).
Matsumura, Y. & Maeda, H. Cancer Res. 46, 6387–6392 (1986).
Hobbs, S. K. et al. Proc. Natl Acad. Sci. USA 95, 4607–4612 (1998).
Wilhelm, S. et al. Nat. Rev. Mater. 1, 16014 (2016).
Anselmo, A. C. & Mitragotri, S. Bioeng. Transl. Med. 4, e10143 (2019).
Shi, J., Kantoff, P. W., Wooster, R. & Farokhzad, O. C. Nat. Rev. Cancer 17, 20–37 (2017).
Petersen, G. H., Alzghari, S. K., Chee, W., Sankari, S. S. & La-Beck, N. M. J. Control Release. 232, 255–264 (2016).
Nel, A., Ruoslahti, E. & Meng, H. ACS Nano. 11, 9567–9569 (2017).
Sindhwani, S. et al. Nat. Mater. https://doi.org/10.1038/s41563-019-0566-2 (2019).
McNeil, S. E. Nat. Rev. Mater. 1, 16073 (2016).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
de Lázaro, I., Mooney, D.J. A nanoparticle’s pathway into tumours. Nat. Mater. 19, 486–487 (2020). https://doi.org/10.1038/s41563-020-0669-9
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41563-020-0669-9
- Springer Nature Limited
This article is cited by
-
Cholesterol-modified sphingomyelin chimeric lipid bilayer for improved therapeutic delivery
Nature Communications (2024)
-
Immune checkpoint inhibition mediated with liposomal nanomedicine for cancer therapy
Military Medical Research (2023)
-
CD22 is a potential target of CAR-NK cell therapy for esophageal squamous cell carcinoma
Journal of Translational Medicine (2023)
-
Mesothelin targeted nano-system enhanced chemodynamic therapy and tirapazamine chemotherapy via lactate depletion
Nano Research (2023)
-
Functional Peptides from One-bead One-compound High-throughput Screening Technique
Chemical Research in Chinese Universities (2023)